| 942 |
Centers for Disease Control and Prevention |
Html |
en |
What You Need to Know About Cerebral Palsy | CDC Features |
Cerebral palsy is the most common motor disability in childhood, and these children need support. Professionals who serve young children play an important role in identifying the early signs and symptoms of cerebral palsy. |
| others—that mark | 0.478193 |
| CDC | 0.432284 |
| specific cause | 0.483665 |
| Professionals | 0.455671 |
| early childhood educators | 0.551988 |
| neurological conditions | 0.471979 |
| disorders | 0.41638 |
| number | 0.41588 |
| muscles | 0.439034 |
| children | 0.703137 |
| estimate | 0.416035 |
| young children | 0.629713 |
| autism spectrum disorder | 0.679919 |
| group | 0.416386 |
| early signs | 0.636576 |
| developmental disabilities | 0.6233 |
| birth | 0.431212 |
| important role | 0.573438 |
| symptoms | 0.479175 |
| exact symptoms | 0.476031 |
| local early intervention | 0.53025 |
| appropriate services | 0.472053 |
| person | 0.480149 |
| support | 0.437616 |
|
| ADDM CP Network | 0.632112 |
| recent report | 0.48306 |
| United States | 0.549579 |
| diverse communities | 0.476805 |
| 8-year-old children | 0.493929 |
| daily activities | 0.478289 |
| co-occurring conditions | 0.475526 |
| supports | 0.432922 |
| spastic CP | 0.574326 |
| local school | 0.468966 |
| Monitoring | 0.415905 |
| characteristics | 0.415874 |
| cases | 0.416302 |
| common motor disability | 0.734148 |
| posture | 0.416886 |
| movement milestones | 0.471649 |
| abnormal brain development | 0.547576 |
| families | 0.448455 |
| CP | 0.867247 |
| pediatricians | 0.4188 |
| valuable resource | 0.478803 |
| cerebral palsy | 0.974339 |
| multiple communities | 0.480091 |
| time | 0.415314 |
|
CLICK HERE |
| 1114 |
Centers for Disease Control and Prevention |
Html |
en |
You Can Control Your Asthma | CDC Features |
Learn to control your asthma. |
| allergies | 0.41507 |
| influenza | 0.414982 |
| asthma medicine | 0.650883 |
| CDC | 0.415812 |
| vaccinations | 0.416289 |
| asthma management plan | 0.712828 |
| asthma site | 0.666175 |
| vaccines | 0.416394 |
| pollen | 0.415987 |
| advice | 0.415795 |
| wheezing | 0.430879 |
| coughing | 0.446017 |
| pneumonia | 0.415989 |
| Regular physical exams | 0.540557 |
| third-hand tobacco smoke | 0.534328 |
| things | 0.432295 |
| chest tightness | 0.495401 |
| lungs | 0.44249 |
| Successful asthma management | 0.741783 |
|
| hospital | 0.415575 |
| episodes | 0.435177 |
| common triggers | 0.474798 |
| asthma attacks | 0.73272 |
| warning signs | 0.48409 |
| cases | 0.415924 |
| dust mites | 0.47636 |
| important thing | 0.477412 |
| Americans | 0.415169 |
| household pets | 0.475063 |
| asthma | 0.912482 |
| lifelong chronic diseases | 0.566062 |
| flu | 0.431034 |
| healthcare provider | 0.610528 |
| person | 0.427978 |
| Respiratory infections | 0.475012 |
| asthma symptoms | 0.670886 |
| breathlessness | 0.416215 |
|
CLICK HERE |
| 4661 |
Centers for Disease Control and Prevention |
Html |
en |
Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System |
null |
| high school | 0.378023 |
| data | 0.291262 |
| health insurance | 0.344181 |
| Risk Factor Surveillance | 0.28749 |
| PSA testing | 0.819899 |
| Prostate cancer treatments | 0.282713 |
| high school education | 0.31159 |
| elevated PSA | 0.30268 |
| BRFSS data | 0.285882 |
| PSA screening test | 0.361756 |
| PSA testing rate | 0.406824 |
| urinary tract symptoms | 0.264849 |
| smoking status | 0.267285 |
| PSA tests | 0.375297 |
| life satisfaction | 0.314139 |
| Preventive Services Task | 0.288986 |
| health care access | 0.281609 |
| prostate cancer symptoms | 0.271131 |
| total PSA testing | 0.336158 |
| PSA screening rate | 0.376904 |
| USPSTF prostate cancer | 0.318087 |
| PSA test | 0.903214 |
| Behavioral Risk Factor | 0.285081 |
| prostate cancer testing | 0.291446 |
|
| study | 0.2947 |
| logistic regression analysis | 0.278643 |
| prostate cancer status | 0.304853 |
| routine checkup | 0.293222 |
| indolent prostate cancers | 0.269528 |
| new USPSTF screening | 0.289712 |
| PSA screening | 0.403785 |
| men | 0.535737 |
| marital status | 0.270734 |
| USPSTF screening recommendation | 0.266489 |
| lower urinary tract | 0.264981 |
| health care | 0.314539 |
| new USPSTF prostate | 0.311145 |
| USPSTF screening guidelines | 0.349343 |
| multiple logistic regression | 0.334404 |
| emotional support | 0.451433 |
| prostate cancer guidelines | 0.272338 |
| Services Task Force | 0.291447 |
| veteran status | 0.265828 |
| prostate cancer screening | 0.325567 |
| prostate cancer | 0.805119 |
| psychosocial factors | 0.339763 |
| high school diploma | 0.370261 |
| coronary heart disease | 0.280406 |
|
CLICK HERE |
| 4979 |
Centers for Disease Control and Prevention |
Html |
en |
An organizing framework for translation in public health: the Knowledge to Action Framework |
null |
| critical translation processes | 0.500157 |
| routine public health | 0.478239 |
| limited public health | 0.485368 |
| public health researchers | 0.47595 |
| public health practitioners | 0.482599 |
| research | 0.536755 |
| translation framework | 0.476271 |
| Health Promotion | 0.491967 |
| Disease Control | 0.497235 |
| entire translation process | 0.481186 |
| widespread public health | 0.478263 |
| public’s health | 0.498984 |
| National Center | 0.480061 |
| organizational capacity | 0.51388 |
| World Health Organization | 0.472431 |
| Teresa J. Brady | 0.491403 |
| NCCDPHP K2A Framework | 0.529592 |
| public health practice | 0.519872 |
| NCCDPHP Work Group | 0.495022 |
| public health impact | 0.517782 |
| translation processes | 0.617815 |
| successful translation processes | 0.490411 |
| effective translation | 0.478149 |
| financial resources | 0.523472 |
| term translation | 0.482042 |
|
| interrelated elements | 0.478999 |
| intentional translation efforts | 0.474272 |
| K2A Framework | 0.699861 |
| successful translation | 0.498764 |
| scientific knowledge | 0.531875 |
| technical assistance | 0.545762 |
| public health outcomes | 0.476568 |
| public health | 0.953393 |
| Katherine M. Wilson | 0.490137 |
| chronic diseases | 0.473252 |
| public health need | 0.478038 |
| entire public health | 0.47212 |
| structures | 0.477035 |
| research phase | 0.479395 |
| public health actions | 0.479103 |
| Work Group | 0.503973 |
| Chronic Disease Prevention | 0.540884 |
| evidence-based programs | 0.583633 |
| translation | 0.756229 |
| evidence-based interventions | 0.517822 |
| federal public health | 0.472371 |
| translation efforts | 0.489581 |
| translation phase | 0.520019 |
| public health agency | 0.490234 |
|
CLICK HERE |
| 7974 |
Centers for Disease Control and Prevention |
Html |
en |
Critical Congenital Heart Defects in the United States - NCBDDD |
null |
| CCHD main screening | 0.434218 |
| specific CCHDs | 0.343097 |
| National Birth Defects | 0.514843 |
| Pregnancy termination rates | 0.359435 |
| Disease Control | 0.340689 |
| children | 0.357598 |
| care facilities | 0.358838 |
| Heart Defects Targeted | 0.594526 |
| training health care | 0.361515 |
| CCHD screening | 0.467624 |
| tricuspid valve atresia | 0.36484 |
| pulmonary venous return | 0.362592 |
| normal screening result | 0.416491 |
| Defects Monitoring Programs | 0.536393 |
| different states | 0.339989 |
| live births | 0.362003 |
| Congenital Heart Defects | 0.602865 |
| simple bedside test | 0.366608 |
| specific CCHD | 0.341714 |
| main screening targets | 0.475356 |
| Molecular Teratology. | 0.357143 |
| newborn screening | 0.686175 |
| defects surveillance programs | 0.665835 |
| Recommended Uniform Screening | 0.472029 |
| Birth Defects Monitoring | 0.546697 |
|
| Essential Public Health | 0.425369 |
| U.S. Recommended Uniform | 0.364777 |
| newborn screening programs | 0.438344 |
| United States | 0.405326 |
| babies | 0.351546 |
| Birth Defects Research | 0.571803 |
| way programs | 0.344973 |
| birth defects surveillance | 0.670514 |
| Public Health Roles | 0.425796 |
| health services | 0.352613 |
| critical congenital heart | 0.789819 |
| congenital heart disease | 0.487833 |
| CCHDs | 0.428054 |
| Pulse Oximetry Screening | 0.563436 |
| Uniform Screening Panel | 0.471899 |
| 50 states | 0.34081 |
| heart syndrome | 0.342317 |
| Population-based Birth Defects | 0.612595 |
| birth defects | 0.961121 |
| certain medical conditions | 0.369692 |
| birth defects data | 0.659331 |
| new U.S. data | 0.379031 |
| CCHD newborn screening | 0.442181 |
| information | 0.357295 |
|
CLICK HERE |
| 9661 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH A-Z Index - G |
null |
| MPEG | 0.741242 |
| site | 0.541063 |
| PDF | 0.544429 |
|
|
CLICK HERE |
| 9813 |
Centers for Disease Control and Prevention |
Html |
en |
Hantavirus - Education Materials and Media |
null |
| sÃndrome pulmonar por | 0.524349 |
| humano por la | 0.448283 |
| Public Health Training | 0.430966 |
| Dr. Barbara Ellis | 0.425906 |
| Dr. Adam MacNeil | 0.435631 |
| Common household disinfectants | 0.407634 |
| infectious diseases | 0.431018 |
| institutional animal care | 0.422345 |
| HPS | 0.446161 |
| Special Pathogens Branch | 0.417514 |
| hantavirus y da | 0.495074 |
| rodent necropsy procedures | 0.435287 |
| Dr. C. J. | 0.42829 |
| public health epidemiologists | 0.430831 |
| federal Animal Welfare | 0.422593 |
| Dr. James Olson | 0.426657 |
| appropriate collection sites | 0.43689 |
| Disease Control | 0.42637 |
| Spanish version | 0.433356 |
| Endangered Species Act | 0.418374 |
| pulmonar por hantavirus | 0.648235 |
| appropriate sample fluids | 0.435431 |
| public information guide | 0.461826 |
| sobre los Hantavirus | 0.619526 |
|
| El sÃndrome pulmonar | 0.419745 |
| Mexico State University | 0.425115 |
| es una enfermedad | 0.416449 |
| Pulmonary Syndrome Clinical | 0.466339 |
| Mexico State Department | 0.421099 |
| causado por virus | 0.436181 |
| Discusses clinical issues | 0.420523 |
| New Mexico State | 0.492368 |
| Dr. Steven Simpson | 0.420565 |
| Sampling Small Mammals | 0.436731 |
| evitar la exposición | 0.421289 |
| Date Released | 0.492868 |
| hantavirus pulmonary syndrome | 0.975296 |
| two-page fact sheet | 0.441166 |
| Dr. Sherif Zaki | 0.434007 |
| Dr. Barbara Knust | 0.44262 |
| hantavirus o SPH | 0.504414 |
| Dr. Fred Koster | 0.426342 |
| Cuando entran los | 0.430325 |
| American Health Organization | 0.452004 |
| Pulmonary Syndrome Fact | 0.499967 |
| manual contains information | 0.456753 |
| infectious zoonotic agent | 0.440149 |
|
CLICK HERE |
| 10067 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH Program Portfolio : Immune Diseases : Goals |
The mission of the NIOSH research program for Immune, Dermal & Infectious Diseases is to eliminate occupational injuries, illnesses, and fatalities among workers in these industries through a focused program of research and prevention. Primary efforts are focused on hazard identification since when potential hazards are recognized, work-related dermal and immune diseases can often be prevented or their effects minimized. |
| occupational asthma | 0.673934 |
| current governmental approaches | 0.672232 |
| effective prevention strategies | 0.654356 |
| significant health risks | 0.690684 |
| normal immune function | 0.90514 |
| risk assessment strategies | 0.663448 |
| altered immune function | 0.744156 |
| immune responses | 0.695158 |
| indoor air chemicals | 0.669711 |
| sector programs | 0.791804 |
| NIOSH sector program | 0.78076 |
| occupational allergen exposures | 0.776647 |
| NIOSH Sector Programs | 0.788906 |
| potential indoor air | 0.65678 |
| infectious cough-generated aerosols | 0.652851 |
| specific allergic mediators | 0.670244 |
| allergic skin sensitization | 0.688585 |
| allergic rhinitis | 0.698576 |
| Intermediate Goal | 0.921013 |
| safer exposure levels | 0.66935 |
| health effects | 0.902367 |
| immune diseases goal | 0.751273 |
| Program Assessment Rating | 0.681504 |
| mold-contaminated workplaces | 0.674902 |
| Provide scientific data | 0.746807 |
|
| immune parameters | 0.669812 |
| NIOSH Immune | 0.738999 |
| adverse health outcomes | 0.683604 |
| cross-sector programs | 0.680975 |
| adverse health effects | 0.677532 |
| Cross Sector programs | 0.705106 |
| NORA Sector Council | 0.680752 |
| program goals | 0.660999 |
| immune function | 0.913089 |
| NIOSH Program Portfolio | 0.761671 |
| associated pathophysiological disorders | 0.661336 |
| certain occupational chemicals | 0.716341 |
| Fishing Program goal | 0.702708 |
| fungal exposure | 0.660668 |
| immune abnormalities | 0.7581 |
| occupational exposures | 0.751568 |
| occupational allergens | 0.725208 |
| clinical disease | 0.670005 |
| indoor air | 0.763389 |
| exposure-related health effects | 0.676322 |
| significant health effects | 0.671699 |
| certain work environments | 0.672218 |
| various sectors | 0.662471 |
| health risks | 0.737673 |
|
CLICK HERE |
| 11886 |
Centers for Disease Control and Prevention |
Html |
en |
Pertussis | Whooping Cough | Prevention | Infants & Children | CDC |
null |
| cold symptoms | 0.604524 |
| DTaP vaccines | 0.575845 |
| DTaP shots | 0.574879 |
| doses | 0.242266 |
| CDC | 0.21973 |
| Español | 0.292722 |
| Tdap shot | 0.584743 |
| best way | 0.663849 |
| babies | 0.592162 |
| pertussis | 0.987679 |
| maximum protection | 0.648495 |
|
| whooping cough | 0.838349 |
| tetanus | 0.256714 |
| dose | 0.230007 |
| Pregnant women | 0.625591 |
| children | 0.62353 |
| Bebés y niños | 0.701859 |
| olds | 0.224315 |
| pertussis vaccine | 0.978059 |
| Prevención | 0.212079 |
| combination vaccine | 0.714881 |
| Parents-to-be | 0.269073 |
|
CLICK HERE |
| 13364 |
Centers for Disease Control and Prevention |
Html |
en |
Student Indoor Tanning | CDC Features |
Learn about two PRCs’ discovery of indoor tanning use among college students. |
| skin cancer | 0.650173 |
| especially indoor tanning | 0.533057 |
| college campuses | 0.388157 |
| American Academy | 0.433008 |
| ID/debit card | 0.391218 |
| research letter | 0.381095 |
| Indoor tanning exposes | 0.581668 |
| Human Services | 0.415646 |
| indoor tanning exposure | 0.538292 |
| San Diego County | 0.375873 |
| Denver researchers | 0.424116 |
| Prevent Skin Cancer. | 0.390952 |
| college ID/debit card | 0.388299 |
| intentional tanning | 0.468887 |
| university debit cards | 0.411373 |
| residential 4-year universities | 0.419887 |
| Prevent Skin Cancer | 0.443859 |
| California census tracts | 0.372752 |
| indoor tanning merchants | 0.54499 |
| student health services | 0.399891 |
| potential health risks | 0.387799 |
| medicine residency program | 0.376666 |
| Skin Cancer Executive | 0.399395 |
| young adult patients | 0.380525 |
|
| Virginia Polytechnic Institute | 0.381767 |
| young adults | 0.385495 |
| Fifty-three universities | 0.37772 |
| debit cards | 0.545731 |
| unlimited indoor tanning | 0.557588 |
| undergraduate student body | 0.389946 |
| Prevention Research Center | 0.398449 |
| student indoor tanning | 0.539166 |
| college students | 0.399925 |
| Research Centers Program | 0.387212 |
| indoor tanning increases | 0.560412 |
| higher risk | 0.390603 |
| indoor tanning salons | 0.620687 |
| Medical School—Worcester PRC | 0.390579 |
| Prevention Research Centers | 0.471525 |
| indoor tanning | 0.911476 |
| Southern New Hampshire | 0.383539 |
| Western Kentucky University | 0.403528 |
| student ID/debit card | 0.388617 |
| Surgeon General | 0.448885 |
| Melanoma results | 0.367357 |
| off-campus housing | 0.393004 |
| frequent indoor tanning | 0.557885 |
| et al | 0.425757 |
|
CLICK HERE |